title: Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii.
abstract: Three clinical isolates, Enterobacter cloacae EC1562 and EC1563 and Citrobacter freundii CFr564, displayed an aminoglycoside resistance profile evocative of low-level 6'-N acetyltransferase type II [AAC(6')-II] production, which conferred reduced susceptibility to gentamicin but not to amikacin or isepamicin. Aminoglycoside acetyltransferase assays suggested the synthesis in the three strains of an AAC(6') which acetylated amikacin practically as well as it acetylated gentamicin in vitro. Both compounds, however, as well as isepamicin, retained good bactericidal activity against the three strains. The aac genes were borne by conjugative plasmids (pLMM562 and pLMM564 of ca. 100 kb and pLMM563 of ca. 20 kb). By PCR mapping and nucleotide sequence analysis, an aac(6')-Ib gene was found in each strain upstream of an ant(3")-I gene in a sulI-type integron. The size of the AAC(6')-Ib variant encoded by pLMM562 and pLMM564, AAC(6')-Ib7, was deduced to be 184 (or 177) amino acids long, whereas in pLMM563 a 21-bp duplication allowing the recruitment of a start codon resulted in the translation of a variant, AAC(6')-Ib8, of 196 amino acids, in agreement with size estimates obtained by Western blot analysis. Both variants had at position 119 a serine instead of the leucine typical for the AAC(6')-Ib variants conferring resistance to amikacin. By using methods that predict the secondary structure, these two amino acids appear to condition an alpha-helical structure within a putative aminoglycoside binding domain of AAC(6')-Ib variants.
authors.affiliation: Service de Microbiologie, Hôpital Saint-Louis, and Université Paris VII, France.
authors.forename: I
authors.initials: I
authors.lastname: Casin
authors.forename: F
authors.initials: F
authors.lastname: Bordon
authors.forename: P
authors.initials: P
authors.lastname: Bertin
authors.forename: A
authors.initials: A
authors.lastname: Coutrot
authors.forename: I
authors.initials: I
authors.lastname: Podglajen
authors.forename: R
authors.initials: R
authors.lastname: Brasseur
authors.forename: E
authors.initials: E
authors.lastname: Collatz
mesh_terms: D000123:Acetyltransferases / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology; D001483:Base Sequence; D016971:Citrobacter freundii / Q000201:enzymology* / Q000235:genetics; D004352:Drug Resistance, Microbial; D016972:Enterobacter cloacae / Q000201:enzymology* / Q000235:genetics; D005839:Gentamicins / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D017433:Protein Structure, Secondary; D016415:Sequence Alignment; D012689:Sequence Homology, Nucleic Acid; D013379:Substrate Specificity
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000123:Acetyltransferases; C056532:aminoglycoside N(6')-acetyltransferase